Spyre Therapeutics (SYRE) revenue

Revenue · fiscal 2023
$886.00K

Spyre Therapeutics (SYRE) reported revenue of $886.00K in fiscal 2023 (the year ended December 31, 2023). That is 62.0% lower than the $2.33M of fiscal 2022. Figures as of 19 Nov 2026, 11:11 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2023
$886.00K
Change on fiscal 2022
−62.0%
Growth, 5 years
−25.6% a year
Highest on record
$18.74Mfiscal 2021
Lowest on record
$886.00Kfiscal 2023
Fiscal years on record
62016–2023

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Spyre Therapeutics revenue, in more detail

Over the five fiscal years to 2023 revenue shrank at a compound 25.6% a year. Across the 6 fiscal years on record (2016–2023), the highest was $18.74M in fiscal 2021 and the lowest $886.00K in fiscal 2023.

History · 6 fiscal years

Revenue by fiscal year

Spyre Therapeutics revenue, year by year

Spyre Therapeutics (SYRE) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2023$886.00K 62.0% down
2022$2.33M 87.6% down
2021$18.74M—
2018$3.89M 25.3% down
2017$5.21M 12.5% up
2016$4.63M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on SYRE

Spyre Therapeutics, figure by figure

Spyre Therapeutics (SYRE) overview: price, valuation and scorecardAll health care companies by market value

Spyre Therapeutics revenue: questions and answers

What is Spyre Therapeutics's revenue?

Spyre Therapeutics (SYRE) reported revenue of $886.00K in fiscal 2023 (the year ended December 31, 2023). That is 62.0% lower than the $2.33M of fiscal 2022.

What is the growth rate of Spyre Therapeutics's revenue?

Over the five fiscal years to 2023 revenue shrank at a compound 25.6% a year.

What are the highest and lowest revenue figures on record for Spyre Therapeutics?

Across the 6 fiscal years on record (2016–2023), the highest was $18.74M in fiscal 2021 and the lowest $886.00K in fiscal 2023.

How is Spyre Therapeutics's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Spyre Therapeutics it is on record here for 6 fiscal years, 2016 to 2023.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Spyre Therapeutics (SYRE) revenue”, data as of 19 November 2026. https://funkfolio.com/stock/SYRE/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.